Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
May 2022	32	Global Markets Direct	ASDR-601533

Published: May 2022 - Pages : 32 - Publisher : Global Markets Direct - Report code : ASDR-601533

ALS Biopharma LLC
Bio-Pharm Solutions Co Ltd
Nobias Therapeutics Inc